DE3871173D1 - - Google Patents

Info

Publication number
DE3871173D1
DE3871173D1 DE88102252T DE3871173T DE3871173D1 DE 3871173 D1 DE3871173 D1 DE 3871173D1 DE 88102252 T DE88102252 T DE 88102252T DE 3871173 T DE3871173 T DE 3871173T DE 3871173 D1 DE3871173 D1 DE 3871173D1
Authority
DE
Germany
Prior art keywords
sterile
carbon atoms
diaminedithiols
ester
radionuclide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE88102252T
Other languages
English (en)
Inventor
Paul Louis Norwood Massachusetts 02062 Us Bergstein
Edward Hollister Townsend Massachusetts 01469 Us Cheesman
Alan David Andover Massachusetts 01810 Us Watson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Pharma Co
Original Assignee
DuPont Merck Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DuPont Merck Pharmaceutical Co filed Critical DuPont Merck Pharmaceutical Co
Application granted granted Critical
Publication of DE3871173D1 publication Critical patent/DE3871173D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/31Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/32Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to an acyclic carbon atom of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005Compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/24Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/29Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE88102252T 1987-02-18 1988-02-17 Expired - Lifetime DE3871173D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1698287A 1987-02-18 1987-02-18
US07/143,561 US5279811A (en) 1987-02-18 1988-01-26 Ester-substituted diaminedithiols and radiolabeled complexes thereof

Publications (1)

Publication Number Publication Date
DE3871173D1 true DE3871173D1 (de) 1992-06-25

Family

ID=26689304

Family Applications (2)

Application Number Title Priority Date Filing Date
DE1994175010 Active DE19475010I2 (de) 1987-02-18 1988-02-17 Durch Estergruppen substituierte Diamindithiole und davon abgeleitete radioaktiv markierte Komplexe
DE88102252T Expired - Lifetime DE3871173D1 (de) 1987-02-18 1988-02-17

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE1994175010 Active DE19475010I2 (de) 1987-02-18 1988-02-17 Durch Estergruppen substituierte Diamindithiole und davon abgeleitete radioaktiv markierte Komplexe

Country Status (18)

Country Link
US (2) US5279811A (de)
EP (1) EP0279417B1 (de)
JP (1) JPH0764802B2 (de)
KR (1) KR910006978B1 (de)
AT (1) ATE76401T1 (de)
AU (1) AU614276B2 (de)
CA (1) CA1271195A (de)
DE (2) DE19475010I2 (de)
DK (1) DK175089B1 (de)
ES (1) ES2042609T3 (de)
GR (1) GR3004986T3 (de)
HK (1) HK66292A (de)
IE (1) IE61254B1 (de)
IL (1) IL85445A (de)
NL (1) NL940008I2 (de)
NZ (1) NZ223552A (de)
PT (1) PT86787B (de)
SG (1) SG71192G (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5279811A (en) * 1987-02-18 1994-01-18 The Du Pont Merck Pharmaceutical Company Ester-substituted diaminedithiols and radiolabeled complexes thereof
US5071965A (en) * 1988-07-19 1991-12-10 Mallinckrodt Medical, Inc. Novel tc-99m complexes
US4925650A (en) * 1988-11-16 1990-05-15 Mallinckrodt, Inc. Technetium -99m complex for examining the renal function
DE69023616T2 (de) * 1989-06-16 1996-04-18 Neorx Corp Radionukleid-chelatverbindungen zur radiomarkierung von proteinen.
FR2664166A1 (fr) * 1990-07-04 1992-01-10 Cis Bio Int Procede de preparation de complexes nitruro de metaux de transition utilisables comme produits radiopharmaceutiques ou pour la synthese de nouveaux produits radiopharmaceutiques.
US5443815A (en) * 1991-11-27 1995-08-22 Diatech, Inc. Technetium-99m labeled peptides for imaging
US7238340B1 (en) 1991-11-27 2007-07-03 Cis Bio International Monoamine, diamide, thiol-containing metal chelating agents
US5997844A (en) * 1991-02-08 1999-12-07 Diatide, Inc. Technetium-99m labeled peptides for imaging
US5965107A (en) * 1992-03-13 1999-10-12 Diatide, Inc. Technetium-99m labeled peptides for imaging
US5192655A (en) * 1991-07-05 1993-03-09 E. I. Du Pont De Nemours And Company Silver halide elements with improved speed and low fog
FR2679452B1 (fr) * 1991-07-22 1993-11-12 Cis Bio International Produit radiopharmaceutique ayant notamment un tropisme cerebral, comportant un complexe nitruro d'un metal de transition, et son procede de preparation.
DE4128183C1 (en) * 1991-08-24 1993-01-14 Forschungszentrum Juelich Gmbh, 5170 Juelich, De New technetium complexes and corresp. complexing agents - useful for measurement of cerebral perfusion, diagnosis of Alzheimer's disease or epilepsy and localisation of tumours
EP0542216A1 (de) * 1991-11-13 1993-05-19 Hoechst Aktiengesellschaft Diaminomercapto (thio)ether als Komplexbildner für in der Nuklearmedizin einsetzbare Nuklide, Verfahren zur Herstellung der Komplexe, sowie Markierungskits, enthaltend diese Komplexe
US5783170A (en) * 1991-11-27 1998-07-21 Diatide, Inc. Peptide-metal chelate conjugates
US5807535A (en) * 1992-07-31 1998-09-15 Australian Nuclear Science & Technology Organisation Metal complexes of hydroxyaryl containing aminocarboxylic acid chelating agents
US5688485A (en) * 1992-12-31 1997-11-18 The Dupont Merck Pharmaceutical Company Radiolabelled complexes of ester-substituted diaminethiols
US5879657A (en) * 1993-03-30 1999-03-09 The Dupont Merck Pharmaceutical Company Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
US5690904A (en) * 1993-07-12 1997-11-25 Amersham International Plc Diagnostic radiopharmaceutical compounds (That)
US20030220233A1 (en) 1994-01-24 2003-11-27 Neorx Corporation Radiolabeled annexins
US5968477A (en) 1994-01-24 1999-10-19 Neorx Corporation Radiolabeled annexin conjugates with hexose and a chelator
CA2190727C (en) * 1994-05-19 2006-07-18 Sudhakar Kasina Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging
IL115099A (en) * 1994-10-14 1999-04-11 Upjohn Co Lyophilizate of phospholipid complex of water insoluble camptothecins
EP0779628A3 (de) * 1995-12-11 1997-07-09 Institut National des Radioéléments, Nationaal Instituut voor Radio-elementen Verfahren zur Stabilisierung einer wässriger Lösung aus Mo99-Molybdat
US5961952A (en) * 1996-01-24 1999-10-05 Dupont Pharmaceuticals Company 99m Tc-tertiary-butyl isonitrile as breast tumor imaging agents
US6005083A (en) * 1997-03-28 1999-12-21 Neorx Corporation Bridged aromatic substituted amine ligands with donor atoms
DE19741694C2 (de) * 1997-09-18 2002-10-31 Schering Ag Verwendung von Komplexen, deren Ligand ein Bis-Amin-Oxim-Derivat oder ein N¶2¶S¶2¶-Derivat und deren Zentralatom ein Radionuklid ist
US6436365B2 (en) * 1997-09-23 2002-08-20 Schering Aktiengesellschaft Process for therapeutic treatment of proliferative diseases
WO1999040882A2 (en) * 1998-02-06 1999-08-19 Trustees Of The University Of Pennsylvania STEREOSELECTIVE Tc-99m LIGANDS
US6692724B1 (en) * 1999-10-25 2004-02-17 Board Of Regents, The University Of Texas System Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
US7067111B1 (en) * 1999-10-25 2006-06-27 Board Of Regents, University Of Texas System Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
CA2410906C (en) * 2000-06-02 2012-10-02 Board Of Regents, The University Of Texas System Ethylenedicysteine (ec)-drug conjugates
US7311893B2 (en) * 2000-07-25 2007-12-25 Neurochem (International) Limited Amyloid targeting imaging agents and uses thereof
CA2444483A1 (en) * 2001-04-26 2002-11-07 Board Of Regents, The University Of Texas System Diagnostic imaging compositions, their methods of synthesis and use
US7261875B2 (en) * 2001-12-21 2007-08-28 Board Of Regents, The University Of Texas System Dendritic poly (amino acid) carriers and methods of use
EP2316493A3 (de) * 2002-11-07 2011-08-10 Board of Regents, The University of Texas System Ethylendicystein(ec)-Aarzneimittelkonjugate, Zusammensetzungen und Verfahren für die gewebsspezifische Darstellung von Krankheiten
US9050378B2 (en) * 2003-12-10 2015-06-09 Board Of Regents, The University Of Texas System N2S2 chelate-targeting ligand conjugates
US7414137B2 (en) * 2006-03-23 2008-08-19 Inspire Pharmaceuticals, Inc. Process for the preparation of 3,4-disubstituted-thiazolidin-2-ones
WO2007111020A1 (ja) 2006-03-24 2007-10-04 Fujifilm Ri Pharma Co., Ltd. 局所脳血流診断用放射性医薬品製造用組成物
US8758723B2 (en) 2006-04-19 2014-06-24 The Board Of Regents Of The University Of Texas System Compositions and methods for cellular imaging and therapy
US10925977B2 (en) * 2006-10-05 2021-02-23 Ceil>Point, LLC Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
KR100891197B1 (ko) * 2008-09-29 2009-04-02 설상준 쌀 세척기
WO2015200187A1 (en) * 2014-06-27 2015-12-30 Reiley Pharmaceuticals, Inc. Conjugates derived from non-steroidal anti-inflammatory drugs and methods of use thereof in imaging
WO2016111834A1 (en) 2015-01-09 2016-07-14 Reiley Pharmaceuticals, Inc. Cox-2-targeting, platinum-containing conjugates and their use in the treatment of tumors and cancers

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB742996A (en) * 1953-01-19 1956-01-04 Dow Chemical Co Di-sulfhydryl alkylene diamine polycarboxylic acids and salts thereof
US2810753A (en) * 1954-05-24 1957-10-22 Dow Chemical Co Metal ion chelating agents
US4284619A (en) * 1978-11-29 1981-08-18 Medi-Physics, Inc. Esters useful as brain imaging agents
US4444690A (en) * 1982-02-25 1984-04-24 University Patents, Inc. Technetium chelates
US4434151A (en) * 1982-11-08 1984-02-28 Medi-Physics, Inc. Bifunctional chelating agents
US4575556A (en) * 1982-11-08 1986-03-11 Medi-Physics, Inc. Bifunctional chelating agents
US4571430A (en) * 1982-11-08 1986-02-18 Medi-Physics, Inc. Homocysteine and homocysteinamide derivatives
US4615876A (en) * 1983-04-25 1986-10-07 Curators Of The University Of Missouri Macrocyclic complexes of technetium-99m for use as diagnostic radionuclides
US4673562A (en) * 1983-08-19 1987-06-16 The Children's Medical Center Corporation Bisamide bisthiol compounds useful for making technetium radiodiagnostic renal agents
US4638051A (en) * 1984-04-30 1987-01-20 The Johns Hopkins University Brain imaging radiopharmaceuticals
US4963688A (en) * 1984-07-19 1990-10-16 University Of Florida Compounds for site-enhanced delivery of radionuclides and uses thereof
US5175343A (en) * 1985-01-14 1992-12-29 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US4897255A (en) * 1985-01-14 1990-01-30 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US4746505A (en) * 1985-04-26 1988-05-24 President And Fellows Of Harvard College Technetium radiodiagnostic fatty acids derived from bisamide bisthiol ligands
ZA863205B (en) * 1985-05-01 1987-08-26 Univ New York State Res Found Diagnostic radiopharmaceutical compounds
DE3772785D1 (de) * 1986-01-23 1991-10-17 Squibb & Sons Inc 1-substituiertes-4,7,10-triscarboxymethyl-1,4,7,10-tetraazacyclododecan und analoga.
US4693688A (en) * 1986-07-14 1987-09-15 Amp Incorporated Grounding connector
US5279811A (en) * 1987-02-18 1994-01-18 The Du Pont Merck Pharmaceutical Company Ester-substituted diaminedithiols and radiolabeled complexes thereof
US5037631A (en) * 1990-10-29 1991-08-06 Mallinckrodt Medical, Inc. Technetium-99M complex for examinating the renal function

Also Published As

Publication number Publication date
NL940008I1 (nl) 1994-07-18
JPS63295549A (ja) 1988-12-01
NL940008I2 (nl) 1999-07-01
CA1271195A (en) 1990-07-03
PT86787B (pt) 1995-03-01
US5279811A (en) 1994-01-18
KR910006978B1 (ko) 1991-09-14
AU1174888A (en) 1988-09-01
DE19475010I2 (de) 2001-07-19
IL85445A0 (en) 1988-07-31
ATE76401T1 (de) 1992-06-15
HK66292A (en) 1992-09-11
EP0279417A2 (de) 1988-08-24
ES2042609T3 (es) 1993-12-16
KR880009917A (ko) 1988-10-05
GR3004986T3 (de) 1993-04-28
PT86787A (pt) 1989-02-28
NZ223552A (en) 1990-04-26
IL85445A (en) 1994-01-25
SG71192G (en) 1992-09-04
US5431900A (en) 1995-07-11
DK81688D0 (da) 1988-02-17
AU614276B2 (en) 1991-08-29
JPH0764802B2 (ja) 1995-07-12
DK175089B1 (da) 2004-05-24
IE880431L (en) 1988-08-18
EP0279417A3 (en) 1989-07-26
EP0279417B1 (de) 1992-05-20
IE61254B1 (en) 1994-10-19
DK81688A (da) 1988-08-19

Similar Documents

Publication Publication Date Title
DE3871173D1 (de)
CS303084A2 (en) Method of 99m technetium's lipophile macrocyclic complexes production
DE3477884D1 (en) Bisamide bisthiol compounds useful for making technetium radiodiagnostic renal agents
CA2034042A1 (en) Boronic acid adducts of rhenium dioxime and technetium-99m dioxime complexes containing a biochemically active group
HK97997A (en) Complexes of technetium-99m with propylene amine oximes
IE791203L (en) Radioactive scanning agents with hydroquinone as stabilizer
DE3571318D1 (en) Complexes of technetium-99m with propylene amine oximes
GR3035997T3 (en) Somastotatin analogs containing chelating groups and their radiolabeled compositions
ZA887113B (en) Boronic acid adducts of rhenium and radioactive isotopes of rhenium dioxime complexes
DE3472532D1 (en) Bone-seeking complexes of technetium-99m
DE3478086D1 (en) Technetium complexes and their uses
IL84895A0 (en) Quaternary halide salts of cinnamate esters,their preparation and their use as sunscreen agents
GB2157283B (en) Esters of 3,5-diacetylamino-2,4,6-triiodobenzoic acid as x-ray contrast agents
GB8728856D0 (en) Tumour-locating agents & method of locating tumours
GB2235448B (en) Boronic acid adducts of technetium-99m dioxime complexes
ES8705389A1 (es) Un procedimiento para preparar una sal de quelato con heterociclo nitrogenado
GB8413279D0 (en) Complexes of technetium-99m with amine oximes
ZA861808B (en) Complexes of technetium-99m with propylene amine oximes
GB8729624D0 (en) Improvements relating to peelable seals

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
V448 Application of spc

Free format text: PRODUCT NAME: BICISAT-DIHYDROCHLORID UND ZINN(II)CHLORID-DIHYDRAT; REGISTRATION NO/DATE: 29602.00.00, 19931209

Spc suppl protection certif: 194 75 010

Filing date: 19940531

8327 Change in the person/name/address of the patent owner

Owner name: DU PONT PHARMACEUTICALS CO., WILMINGTON, DEL., US

V457 Spc granted

Free format text: PRODUCT NAME: BICISAT-DIHYDROCHLORID UND ZINN(II)CHLORID-DIHYDRAT; REGISTRATION NO/DATE: 29602.00.00, 19931209

Spc suppl protection certif: 194 75 010

Filing date: 19940531

8327 Change in the person/name/address of the patent owner

Owner name: BRISTOL-MYERS SQUIBB PHARMA CO., PRINCETON, N.J.,

V464 Spc expired

Free format text: PRODUCT NAME: BICISAT-DIHYDROCHLORID UND ZINN(II)CHLORID-DIHYDRAT; REGISTRATION NO/DATE: 29602.00.00, 19931209

Spc suppl protection certif: 194 75 010

Filing date: 19940531